Skip to main content

Chase Therapeutics

Washington, United States

Chase Therapeutics is an early-stage, product-based specialty pharmaceutical company

$20.0M raised
Oct 2021
Series B

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Chase Therapeutics

How much funding has Chase Therapeutics raised?
Chase Therapeutics has raised $20.0M in total funding. The most recent round was Series B. The last funding was announced in October 2021.
Who are Chase Therapeutics's investors?
Chase Therapeutics's investors include Revolution, Revolution’s Rise of the Rest Seed Fund, Brain Trust Accelerator Fund, China Link Capital.
Where is Chase Therapeutics headquartered?
Chase Therapeutics is headquartered in Washington, United States.
What does Chase Therapeutics do?
Chase Therapeutics is an early-stage, product-based specialty pharmaceutical company
What stage is Chase Therapeutics at?
Chase Therapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Chase Therapeutics — Funding & Investors." VCBacked, October 20, 2021, https://www.vcbacked.co/company/chase-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2021). Chase Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/chase-therapeutics
Wikipedia (cite web)
{{cite web |title=Chase Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/chase-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .